SEARCH RESULTS FOR:
José Vizquerra
PRESIDENT & CEO, O3 MINING
"Our strategy is focused on Val-d'Or, where our Marban and Alpha projects cover important segments of the Cadillac Fault or its subsidiary structures."
Daniel W. Kappes
PRESIDENT & CEO, KAPPES, CASSIDAY & ASSOCIATES (KCA)
“KCA is one of the pioneering firms in precious metals heap leaching.”
Gary Lewis
GROUP CEO, NEVADA SILVER CORPORATION
“We believe we can increase the grade and tonnes significantly at Corcoran and see the current resource estimate as an excellent starting point.”
Felipe Varela
DIRECTOR GENERAL, GRUPO DYNASOL
“In Mexico, we are the benchmark of the synthetic rubber industry, and thanks to the current capacity that we have, we export around 60% of our production.”
Alonzo Autrey
MANAGING DIRECTOR, DVA MEXICANA
“In countries like Mexico, everything related to chronic degenerative illnesses will be a priority for laboratories focused on generic products. The demand for these products means there is an opportunity to have generic treatments available at lower prices.”
Federico Veller
GENERAL MANAGER, PROFERTIL S.A.
Latin America Petrochemicals and Chemicals 2021 - Digital Interactive
"We are aiming to soon supply at least 80% of the Argentinian demand for urea, with any excess going to the Brazilian market."
Johan le Roux
DIRECTOR, MANDELA MINING PRECINCT
MACIG Southern Africa 2021 - Digital Interactive
"The Mandela Mining Precinct is working with key stakeholders to look into the possibility of establishing an underground testing facility."
Stéphane Rabut
GLOBAL EXPLOSIVES DIRECTOR, TITANOBEL
MACIG West Africa 2021-2022
"Africa remains our primary focus, providing many opportunities driven by a vibrant mining industry, as well as less competition and the possibility of attaining a larger market share."
Doris Afanyedey
GENERAL MANAGER, CUMMINS GHANA
MACIG West Africa 2021-2022
"The mining sector across West Africa is ripe with opportunities and we are looking to expand our network of dealers."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
